Antibodies from myasthenic patients that compete with cholinergic agents for binding to nicotinic receptors.
Open Access
- 1 July 1980
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 77 (7), 4326-4330
- https://doi.org/10.1073/pnas.77.7.4326
Abstract
Ig from sera of [myasthenia gravis] patients were purified; antibodies directed against the cholinergic ligand-binding site of the nicotinic acetylcholine receptor were identified. In the serum of 1 patient analyzed in detail these antibodies belonged to the IgG3 class. In chicken embryo myogenic cultures, antibody binding was competitive with 125I-labeled .alpha.-bungarotoxin and irreversible on a time scale of hours. 125I-labeled .alpha.-bungarotoxin was not displaced by antibody from preformed complexes and, conversely, antibody was not displaced by toxin; Antibody binding was competitive with some, but not all, nicotinic agents. Acetylcholine, carbamoylcholine and dimethyltubocurarine competed effectively; decamethonium and hexamethonium did not, suggesting the 2 classes of nicotinic ligands probably interact at different, nonoverlapping receptor subsites. There was no competitive binding between these antibodies and the muscarinic antagonist atropine. This class of myasthenic Ig and rabbit antibodies raised against Torpedo acetylcholine receptors increased the rate of receptor degradation. Synthesis and degradation remained coupled; there was a compensating increase in receptor synthesis. Ig directed against the ligand-binding site of acetylcholine receptors may account for the characteristic curare-like symptoms of early myasthenia and their response to cholinesterase inhibition, for the apparent decrease in receptors measurable by 125I-labeled .alpha.-bungarotoxin binding, and for initiating localized complement activation at the postsynaptic membrane.This publication has 21 references indexed in Scilit:
- Immune complexes (IgG and C3) at the motor end-plate in myasthenia gravis: ultrastructural and light microscopic localization and electrophysiologic correlations.1977
- Accelerated degradation of acetylcholine receptor from cultured rat myotubes with myasthenia gravis sera and globulins.Proceedings of the National Academy of Sciences, 1977
- Human myasthenic sera reduce acetylcholine sensitivity of human muscle cells in tissue cultureNature, 1977
- Myasthenic Immunoglobulin Accelerates Acetylcholine Receptor DegradationScience, 1977
- Immunoglobulins in myasthenia gravis: effect of human lymph IgG 3 and F(ab‘)2 fragments on a cholinergic receptor preparation from Torpedo marmorata*European Journal of Clinical Investigation, 1977
- Antibody to acetylcholine receptor in myasthenia gravisNeurology, 1976
- SERUM ACETYLCHOLINE‐RECEPTOR ANTIBODIES IN MYASTHENIA GRAVIS*Annals of the New York Academy of Sciences, 1976
- Accessibility to antibodies of acetylcholine receptors in the neuromuscular junction.1976
- Interaction of myasthenic serum globulin with the acetylcholine receptorBiochimica et Biophysica Acta (BBA) - Protein Structure, 1975
- Neuromuscular Junction in Myasthenia Gravis: Decreased Acetylcholine ReceptorsScience, 1973